Ketazolam

Ketazolam

File:Ketazolam3d.png
Clinical data
Pregnancy category	?
Routes of administration	Oral
ATC code	N05BA10 (WHO)
Legal status
Legal status	Schedule IV(US)
Pharmacokinetic data
Bioavailability	?
Metabolism	Hepatic
Elimination half-life	26-200 hours
Excretion	Renal
Identifiers
IUPAC name ?
CAS Number	27223-35-4
PubChem CID	33746
DrugBank	?
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H17ClN2O3
Molar mass	368.8

Ketazolam (marketed under brand names Anseren, Anxon, Contamex, Loftran, Marcen, Sedotime, Solatran, Unakalm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.

Ketazolam is not approved for sale in the United States or Canada. In South Africa, GlaxoSmithKline markets ketazolam under its Solatran trademark.[1] The U.S. Food and Drug Administration warns[2] that in Spain, ketazolam marketed as Marcen may sometimes be mistakenly confused with Narcan.

Brand Names

NAME	COUNTRY
Anseren	Italy
Ansieten	Argentina
Ansietil	Chile , Ecuador
Marcen	Spain
Sedatival	Chile
Solatran	South Africa, Bélgica, Suíça
Sedotime	Spain
Unakalm	Portugal, Países Baixos

Other names

U 28774; Anxon;[3] Contamex; Loftran; DEA No. 2772[4];